A comparetive study of Arnebia Euchroma Vaginal Cream and Clotrimazole Vaginal Cream’s effectiveness on Candida Vulvovaginitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190303042889N2

Enrollment

Registered

2021-04-04

Start date

2017-04-21

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidiasis Vulvuvaginitis. Candidiasis of vulva and vagina

Interventions

Intervention 1: Intervention group: Use of vaginal ointment 1% aqueous extract of Onosma dichroanthum Boissmade in Mashhad School of Pharmacy, one applicator a day for 7 days. Intervention 2: Interven

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Candida Vulvovaginitis

Exclusion criteria

Exclusion criteria: Pregnancy Comorbidity Medication

Design outcomes

Primary

Measure	Time frame
Candidiasis Vulvuvaginitis in direct smear of vaginal discharge. Timepoint: Baseline and the end of the treatment. Method of measurement: Presence of Candida in direct smear of vaginal discharge.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyedeh Zhahra HabibianNejad

Mashhad University of Medical Sciences

Habibiannezhadz971@mums.ac.ir+98 51 3221 4363

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026